127 related articles for article (PubMed ID: 22959901)
1. Association of body mass index with removal of etonogestrel subdermal implant.
Casey PM; Long ME; Marnach ML; Fleming-Harvey J; Drozdowicz LB; Weaver AL
Contraception; 2013 Mar; 87(3):370-4. PubMed ID: 22959901
[TBL] [Abstract][Full Text] [Related]
2. Management of etonogestrel subdermal implant-related bleeding.
Casey PM; Long ME; Drozdowicz LB; Marnach ML; Weaver AL
J Reprod Med; 2014; 59(5-6):306-12. PubMed ID: 24937974
[TBL] [Abstract][Full Text] [Related]
3. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.
Ireland LD; Goyal V; Raker CA; Murray A; Allen RH
Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904
[TBL] [Abstract][Full Text] [Related]
4. Bleeding related to etonogestrel subdermal implant in a US population.
Casey PM; Long ME; Marnach ML; Bury JE
Contraception; 2011 May; 83(5):426-30. PubMed ID: 21477684
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel.
Funk S; Miller MM; Mishell DR; Archer DF; Poindexter A; Schmidt J; Zampaglione E;
Contraception; 2005 May; 71(5):319-26. PubMed ID: 15854630
[TBL] [Abstract][Full Text] [Related]
6. Etonogestrel Implants in Adolescents: Experience, Satisfaction, and Continuation.
Obijuru L; Bumpus S; Auinger P; Baldwin CD
J Adolesc Health; 2016 Mar; 58(3):284-9. PubMed ID: 26903428
[TBL] [Abstract][Full Text] [Related]
7. Insertion and 3-year follow-up experience of 372 etonogestrel subdermal contraceptive implants by family physicians in Granada, Spain.
Arribas-Mir L; Rueda-Lozano D; Agrela-Cardona M; Cedeño-Benavides T; Olvera-Porcel C; Bueno-Cavanillas A
Contraception; 2009 Nov; 80(5):457-62. PubMed ID: 19835720
[TBL] [Abstract][Full Text] [Related]
8. Indications for removal of etonogestrel implant within two years of use in Jos, Nigeria.
Mutihir JT; Nyango DD
East Afr Med J; 2010 Nov; 87(11):461-4. PubMed ID: 23457809
[TBL] [Abstract][Full Text] [Related]
9. Six- and twelve-month documented removal rates among women electing postpartum inpatient compared to delayed or interval contraceptive implant insertions after Medicaid payment reform.
Crockett AH; Pickell LB; Heberlein EC; Billings DL; Mills B
Contraception; 2017 Jan; 95(1):71-76. PubMed ID: 27400823
[TBL] [Abstract][Full Text] [Related]
10. Side effects and acceptability of Implanon: a pilot study conducted in eastern Turkey.
Yildizbas B; Sahin HG; Kolusari A; Zeteroglu S; Kamaci M
Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):248-52. PubMed ID: 17763263
[TBL] [Abstract][Full Text] [Related]
11. Immediate postpartum etonogestrel implant: a contraception option with long-term continuation.
Wilson S; Tennant C; Sammel MD; Schreiber C
Contraception; 2014 Sep; 90(3):259-64. PubMed ID: 24993485
[TBL] [Abstract][Full Text] [Related]
12. Bleeding profile in users of an etonogestrel sub-dermal implant: effects of anthropometric variables. An observational uncontrolled preliminary study in Italian population.
Di Carlo C; Guida M; De Rosa N; Sansone A; Gargano V; Cagnacci A; Nappi C
Gynecol Endocrinol; 2015 Jun; 31(6):491-4. PubMed ID: 26213863
[TBL] [Abstract][Full Text] [Related]
13. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study.
Brito MB; Ferriani RA; Quintana SM; Yazlle ME; Silva de Sá MF; Vieira CS
Contraception; 2009 Dec; 80(6):519-26. PubMed ID: 19913145
[TBL] [Abstract][Full Text] [Related]
14. Menstrual bleeding patterns in adolescents using etonogestrel (ENG) implant.
Deokar AM; Jackson W; Omar HA
Int J Adolesc Med Health; 2011; 23(1):75-7. PubMed ID: 21721368
[TBL] [Abstract][Full Text] [Related]
15. One-year assessment of women receiving sub-dermal contraceptive implant at Siriraj Family Planning Clinic.
Thamkhantho M; Jivasak-Apimas S; Angsuwathana S; Chiravacharadej G; Intawong J
J Med Assoc Thai; 2008 Jun; 91(6):775-80. PubMed ID: 18697372
[TBL] [Abstract][Full Text] [Related]
16. The effect of mefenamic acid on controlling irregular uterine bleeding second to Implanon use.
Phaliwong P; Taneepanichskul S
J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S64-8. PubMed ID: 21213495
[TBL] [Abstract][Full Text] [Related]
17. Tolerability and clinical safety of Implanon.
Blumenthal PD; Gemzell-Danielsson K; Marintcheva-Petrova M
Eur J Contracept Reprod Health Care; 2008 Jun; 13 Suppl 1():29-36. PubMed ID: 18330815
[TBL] [Abstract][Full Text] [Related]
18. Continuation of the etonogestrel implant in women undergoing immediate postabortion placement.
Madden T; Eisenberg DL; Zhao Q; Buckel C; Secura GM; Peipert JF
Obstet Gynecol; 2012 Nov; 120(5):1053-9. PubMed ID: 23090522
[TBL] [Abstract][Full Text] [Related]
19. Etonogestrel implant in postpartum adolescents: bleeding pattern, efficacy and discontinuation rate.
Guazzelli CA; de Queiroz FT; Barbieri M; Torloni MR; de Araujo FF
Contraception; 2010 Sep; 82(3):256-9. PubMed ID: 20705154
[TBL] [Abstract][Full Text] [Related]
20. Etonogestrel implant as a contraceptive choice; patient acceptability and adverse effect profile in a general practice setting.
Riney S; O'Shea B; Forde A
Ir Med J; 2009 Jan; 102(1):24-5. PubMed ID: 19284015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
